Health in Latvia
308 indicators covering health for Latvia.
| Indicator | Latest | Year | 10-yr change | Rank |
|---|---|---|---|---|
| Age population, age 21, female, interpolated | 8,794 | 2025 | down 16.7% | 156th |
| Age population, age 25, male, interpolated | 8,937 | 2025 | down 37.8% | 157th |
| Age population, age 25, female, interpolated | 8,436 | 2025 | down 37.6% | 157th |
| Mortality rate, under-5, female | 2.3 per 1,000 live births | 2024 | down 54.9% | 183rd |
| Survival to age 65, male | 71.1% | 2024 | up 8.7% | 122nd |
| Survival to age 65, female | 88.1% | 2024 | up 2.1% | 85th |
| Fertility rate, total | 1.24 births per woman | 2024 | down 24.8% | 193rd |
| Life expectancy at birth, male | 71.6 years | 2024 | up 3.6% | 106th |
| Life expectancy at birth, total | 76.43 years | 2024 | up 3.1% | 93rd |
| Life expectancy at birth, female | 81.5 years | 2024 | up 2.6% | 63rd |
| Mortality rate, infant, male | 2.3 per 1,000 live births | 2024 | down 54.0% | 182nd |
| Mortality rate, infant | 2.2 per 1,000 live births | 2024 | down 53.2% | 181st |
| Mortality rate, infant, female | 2 per 1,000 live births | 2024 | down 53.5% | 182nd |
| Death rate, crude | 14.3 per 1,000 people | 2024 | unchanged | 4th |
| Birth rate, crude | 6.9 per 1,000 people | 2024 | down 36.7% | 201st |
| Mortality rate, adult, male | 214.54 per 1,000 male adults | 2024 | down 11.1% | 71st |
| Mortality rate, adult, female | 74.3 per 1,000 female adults | 2024 | down 16.5% | 128th |
| Immunization, Pol3 | 97.0% | 2024 | up 5.4% | 29th |
| Immunization, BCG | 99.0% | 2024 | up 7.6% | 1st |
| Children per woman that survived childhood vs. those that died in childhood | 0.0041 under-five deaths per woman | 2024 | down 55.2% | 190th |
| Mortality rate, under-5 | 2.5 per 1,000 live births | 2024 | down 55.4% | 184th |
| Mortality rate, under-5, male | 2.7 per 1,000 live births | 2024 | down 55.0% | 185th |
| Immunization, measles | 98.0% | 2024 | up 3.2% | 20th |
| Immunization, DPT | 97.0% | 2024 | up 5.4% | 29th |
| Mortality rate, neonatal | 1.2 per 1,000 live births | 2024 | down 60.0% | 186th |
| Life expectancy | 76.19 years | 2023 | up 2.7% | 106th |
| Lifetime risk of maternal death | 0.0% | 2023 | down 37.1% | 137th |
| Lifetime risk of maternal death | 4,958 1 in: rate varies by country | 2023 | up 59.1% | 58th |
| Number of maternal deaths | 3 | 2023 | down 40.0% | 147th |
| Maternal mortality ratio | 19 | 2023 | down 20.8% | 123rd |
| Probability of dying among children ages 5-9 years, female | 0.5 per 1,000 | 2024 | down 37.5% | 151st |
| Probability of dying among children ages 5-9 years, male | 0.5 per 1,000 | 2024 | down 50.0% | 156th |
| Probability of dying among adolescents ages 10-14 years, female | 0.5 per 1,000 | 2024 | down 37.5% | 157th |
| Probability of dying among adolescents ages 10-14 years, male | 0.5 per 1,000 | 2024 | down 44.4% | 166th |
| Probability of dying among adolescents ages 10-19 years, female | 1.7 per 1,000 | 2024 | down 22.7% | 154th |
| Probability of dying among adolescents ages 10-19 years, male | 3.1 per 1,000 | 2024 | down 27.9% | 148th |
| Probability of dying among adolescents ages 15-19 years, female | 1.2 per 1,000 | 2024 | down 20.0% | 142nd |
| Probability of dying among adolescents ages 15-19 years, male | 2.5 per 1,000 | 2024 | down 26.5% | 144th |
| Probability of dying among adolescents ages 10-19 years | 2.4 per 1,000 | 2024 | down 27.3% | 151st |
| Probability of dying among youth ages 20-24 years, female | 1.7 per 1,000 | 2024 | down 15.0% | 131st |
| Probability of dying among youth ages 20-24 years, male | 4.1 per 1,000 | 2024 | down 25.5% | 139th |
| Women's share of population ages 15+ living with HIV | 37.0% | 2024 | up 4.4% | 79th |
| Prevalence of HIV, female | 0.1% | 2024 | unchanged | 58th |
| Prevalence of HIV, male | 0.1% | 2024 | unchanged | 70th |
| Incidence of HIV, ages 15-49 | 0.19 per 1,000 uninfected population ages 15-49 | 2024 | down 61.2% | 73rd |
| Incidence of HIV, all | 0.1 per 1,000 uninfected population | 2024 | down 60.0% | 77th |
| Prevalence of overweight | 59.3% | 2022 | up 8.8% | 76th |
| Prevalence of overweight, female | 50.3% | 2022 | up 3.6% | 111th |
| Prevalence of overweight, male | 67.9% | 2022 | up 12.6% | 38th |
| Immunization, HepB3 | 99.0% | 2024 | up 7.6% | 1st |
| Life expectancy at age 15 | 86.68 years | 2100 | up 1.3% | 122nd |
| Incidence of HIV, ages 50+ | 0.1 per 1,000 uninfected population ages 50+ | 2024 | unchanged | 38th |
| Adults (ages 15+) and children (0-14 years) living with HIV | 6,100 | 2024 | unchanged | 109th |
| Incidence of HIV, ages 15-24 | 0.1 per 1,000 uninfected population ages 15-24 | 2024 | down 50.0% | 87th |
| Population ages 55-59, male | 6.7% | 2025 | down 5.8% | 45th |
| Population ages 55-59, female | 6.7% | 2025 | down 8.4% | 44th |
| Population ages 20-24, male | 45,863 | 2025 | down 24.9% | 155th |
| Population ages 75-79, female | 5.2% | 2025 | down 7.7% | 17th |
| Population ages 80 and above, male | 3.4% | 2025 | up 29.3% | 41st |
| Population ages 80 and above, female | 8.6% | 2025 | up 23.8% | 7th |